INCY · Incyte Corp · Webcasts, Transcripts & Audio
$116.50
-4.85 (-4.00%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$24.75B
Shares
199.78M
Volume · Oct 1
2.37M
Avg daily vol (3M)
1.6M
Incyte Corp Webcasts
Earnings calls, investor updates, investor days and conferences for Incyte Corp (INCY), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲1.3%
$823.30M
$112.78M
'22 Q3
22-11-01
▲7.4%
$926.70M
$28.46M
'22 Q4
23-02-07
▲10.3%
$808.67M
$21.70M
'23 Q1
23-05-02
▲4.7%
$954.61M
$203.55M
'23 Q2
23-08-01
▲11.6%
$919.02M
$171.27M
'23 Q3
23-10-31
▲9.3%
$1.01B
$201.08M
'23 Q4
24-02-13
▲8.9%
$880.89M
$169.55M
'24 Q1
24-04-30
▲9.3%
$1.04B
−$444.60M
'24 Q2
24-07-30
▲23.8%
$1.14B
$106.46M
'24 Q3
24-10-29
▲16.3%
$1.18B
$201.21M
'24 Q4
25-02-10
▲19.5%
$1.05B
$158.20M
'25 Q1
25-04-29
▲16.5%
$1.22B
$405.00M
'25 Q2
25-07-29
▲20%
$1.37B
$424.17M
'25 Q3
25-10-28
▲27.8%
$1.51B
$299.28M
'25 Q4
26-02-10
LATEST
▲20.9%
$1.27B
$303.33M
'26 Q1
26-04-28
Conference
Investor event
2026-09-09
Incyte Corp (INCY) September 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-28
Incyte Corp (INCY) Q2 2026 Earnings Call Transcript
Confident tone
Late-stage pipeline advancement
Jackify XR launch and core franchise
Operational execution and company transition
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-09
Incyte Corp (INCY) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-08
Incyte Corp (INCY) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-28
Incyte Corp (INCY) Q1 2026 Earnings Call Transcript
Confident tone
Geographic and international growth
Core business expansion beyond Jakify
Pipeline and regulatory milestones
Revenue
$1.27B
▲ 20.9% YoY Diluted EPS
$1.47
▲ 83.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-11
Incyte Corp (INCY) March 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-02-10
Incyte Corp (INCY) Q4 2025 Earnings Call Transcript
Confident tone
2025 Financial Performance and 2026 Outlook
Pipeline Risks and Clinical Readouts
Jakafi Franchise and Jakafi XR
Revenue
$1.51B*
▲ 27.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Incyte Corp (INCY) Q3 2025 Earnings Call Transcript
Confident tone
Hem/onc innovation focus (MPNs, 989, 617)
Niktimvo launch trajectory
Jakafi performance and guidance raise
Revenue
$1.37B
▲ 20% YoY Diluted EPS
$2.11
▲ 290.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
Incyte Corp (INCY) Q2 2025 Earnings Call Transcript
Confident tone
Pipeline catalysts (989, povorcitinib, axatilimab)
Jakafi demand outlook and IRA
Niktimvo launch
Revenue
$1.22B
▲ 16.5% YoY Diluted EPS
$2.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Incyte Corp (INCY) Q1 2025 Earnings Call Transcript
Confident tone
Jakafi commercial performance and guidance raise
Financial results and operating expenses
KRAS G12D inhibitor competitive landscape
Revenue
$1.05B
▲ 19.5% YoY Diluted EPS
$0.80
▲ 6.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-10
Incyte Corp (INCY) Q4 2024 Earnings Call Transcript
Confident tone
Jakafi (ruxolitinib) performance and guidance
Opzelura growth and pediatric atopic dermatitis launch
2025 pipeline catalysts and pivotal readouts
Revenue
$1.18B*
▲ 16.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-29
Incyte Corp (INCY) Q3 2024 Earnings Call Transcript
Confident tone
Opzelura growth and geographic expansion
Jakafi commercial performance and guidance raise
CDK2 inhibitor competitive positioning
Revenue
$1.14B
▲ 23.8% YoY Diluted EPS
$0.54
▼ 28.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-30
Incyte Corp (INCY) Q2 2024 Earnings Call Transcript
Confident tone
Opzelura growth and expansion
Jakafi commercial performance and guidance
Pipeline transformation and prioritization
Revenue
$1.04B
▲ 9.3% YoY Diluted EPS
$-2.04
▼ 326.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-30
Incyte Corp (INCY) Q1 2024 Earnings Call Transcript
Positive tone
Jakafi performance
Opzelura growth
Pipeline launches by 2030
Revenue
$880.89M
▲ 8.9% YoY Diluted EPS
$0.75
▲ 650% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-13
Incyte Corp (INCY) Q4 2023 Earnings Call Transcript
Confident tone
Opzelura launch momentum
Jakafi commercial performance and 2024 guidance
Pipeline and ten high-impact launches by 2030
Revenue
$1.01B*
▲ 9.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-31
Incyte Corp (INCY) Q3 2023 Earnings Call Transcript
Revenue
$919.02M
▲ 11.6% YoY Diluted EPS
$0.76
▲ 52% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-01
Incyte Corp (INCY) Q2 2023 Earnings Call Transcript
Revenue
$954.61M
▲ 4.7% YoY Diluted EPS
$0.90
▲ 25% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Incyte Corp (INCY) Q1 2023 Earnings Call Transcript
Revenue
$808.67M
▲ 10.3% YoY Diluted EPS
$0.10
▼ 41.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-07
Incyte Corp (INCY) Q4 2022 Earnings Call Transcript
Revenue
$926.70M*
▲ 7.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Incyte Corp (INCY) Q3 2022 Earnings Call Transcript
Revenue
$823.30M
▲ 1.3% YoY Diluted EPS
$0.50
▼ 39% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Incyte Corp (INCY) Q2 2022 Earnings Call Transcript
Revenue
$911.40M
▲ 29.1% YoY Diluted EPS
$0.72
▲ 7.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Incyte Corp (INCY) Q1 2022 Earnings Call Transcript
Revenue
$733.24M
▲ 21.3% YoY Diluted EPS
$0.17
▼ 29.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-08
Incyte Corp (INCY) Q4 2021 Earnings Call Transcript
Revenue
$862.85M*
▲ 9.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Incyte Corp (INCY) Q3 2021 Earnings Call Transcript
Revenue
$812.99M
▲ 31% YoY Diluted EPS
$0.82
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-03
Incyte Corp (INCY) Q2 2021 Earnings Call Transcript
Revenue
$705.71M
▲ 2.6% YoY Diluted EPS
$0.67
▼ 49.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Incyte Corp (INCY) Q1 2021 Earnings Call Transcript
Revenue
$604.72M
▲ 6.4% YoY Diluted EPS
$0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-09
Incyte Corp (INCY) Q4 2020 Earnings Call Transcript
Revenue
$789.51M
▲ 36.3% YoY Diluted EPS
$0.68
▲ 33.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Incyte Corp (INCY) Q3 2020 Earnings Call Transcript
Revenue
$620.64M
▲ 12.5% YoY Diluted EPS
$-0.07
▼ 111.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Incyte Corp (INCY) Q2 2020 Earnings Call Transcript
Revenue
$688.04M
▲ 29.8% YoY Diluted EPS
$1.32
▲ 175% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Incyte Corp (INCY) Q1 2020 Earnings Call Transcript
Revenue
$568.51M
▲ 14.2% YoY Diluted EPS
$-3.33
▼ 808.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
Incyte Corp (INCY) Q4 2019 Earnings Call
Revenue
$579.39M
▲ 9.6% YoY Diluted EPS
$0.51
▲ 59.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–31 of 31 webcasts
Key facts
CIK
879169
CUSIP
45337C102
13F (30d)
17 filings
13 filers
Visit website
Investor relations